• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Glycorex Transplantation (GTAB B): Signs distribution agreement in Argentina for Glycosorb® ABO

GTAB BRegulatory press release06.08.2026, 07.01
Download the release

As part of its continued international growth strategy, Glycorex Transplantation AB (publ) has entered into a distribution agreement with Buenos Aires-based Stone Fly Salud SA for the rights to Glycosorb® ABO (CE-marked) in Argentina.

Stone Fly Salud SA specializes in the distribution of pharmaceuticals and medical products, having operated in the Argentine market since 2006. The company works closely with local healthcare providers to supply critical medical technologies across the region.

The agreement opens a significant market opportunity for Glycorex, as Argentina performs approximately 1,600 kidney transplants annually across more than 60 specialized centers.

"We are pleased to finalize this agreement and look forward to working alongside the Stone Fly Salud team," says Carl Magnus Schultz CEO at Glycorex Transplantation. "Together, we will make Glycosorb® ABO products accessible for ABO-incompatible transplantations and transfusion medicine applications throughout Argentina."